The transaction places Sidekick in a position to potentially introduce the Zanadio PDT to payer partners in the US. But will CMS struggles loom in the shadows?
By Colin Kellaher Akili on Friday unveiled a management realignment, as the digital-medicine company continues its shift to a non-prescription business.
Akili, Inc (AKLI) announces Chamath Palihapitiya has resigned from the Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Co-founder and CEO Eddie Martucci, Ph.D. transitions to role of Board chair; Matt Franklin, president and chief operating officer of Akili, appointed president and chief executive officer
.
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model. The company plans to pursue regulatory approval for over-the-counter labeling of its products .